The role of cardiothoracic surgeons in advocating against payment cuts

Cardiothoracic surgeons sit at a consequential point in health care. Cardiac and thoracic operations depend on operating theatres, anaesthesia, perfusion, intensive care, imaging, devices and teams that work beyond the hours of a routine clinic visit. That makes the clinical consequences of reduced reimbursement easy to describe but difficult to isolate, because a payment decision affects several services at once.

Surgeons also see how policy reaches patients. A lower fee may influence private-insurer agreements, hospital rosters, elective operating lists or the capacity to maintain emergency cardiac and thoracic services. Australian patients generally move through a mixed system of public hospitals, Medicare-funded services and private insurance, often after a GP referral and with variable out-of-pocket costs. Surgeons can connect those local experiences to national debates without treating every problem as a fee issue.

In the United States, the American College of Cardiology’s patient access campaign was created to oppose Medicare Physician Fee Schedule cuts and demonstrated how clinical expertise can support legislative, legal and public responses. Its resources on policy, practice effects and patient stories offer a useful model, not a substitute for Australian evidence. The local task is to translate that approach for Medicare Benefits Schedule rebates, Commonwealth decisions and the contractual arrangements that shape access here.

Why payment reductions threaten surgical care

Payment cuts threaten more than surgeon income. Cardiac surgery requires costly disposables, heart-lung support and long intensive-care stays; thoracic procedures may involve expensive implants and postoperative care. If a reimbursement framework treats those inputs as one procedure, underpayment can become under-resourcing. Advocacy must therefore show the full pathway of care, not merely the consultant’s line item.

A fee reduction can alter behaviour at several points. Hospitals may prioritise shorter or more predictable cases, reduce emergency theatre availability, delay equipment replacement or limit time for complex operating lists. Training positions can weaken when services cannot sustain supervision and after-hours cover. For patients, these effects appear as longer waits, transfers between hospitals or a narrower range of local treatment.

Distinguishing a headline percentage cut from its real effect matters. In the United States, Medicare Physician Fee Schedule reductions raised concerns about access to cardiovascular care, including the sustainability of office-based and procedural services. In Australia, the Medicare Benefits Schedule operates differently, and private insurers negotiate separate arrangements. Claims that a proposed Australian change will reproduce U.S. outcomes require local modelling, while claims of no effect should be tested against workforce, theatre and insurer data.

Defining the surgeon’s advocacy role

Surgeons contribute three forms of authority advocates rarely possess elsewhere: procedural knowledge, longitudinal patient relationships and institutional oversight. They can identify which parts of a case mix are vulnerable, explain why clinical urgency cannot be reduced to efficiency metrics, and distinguish a temporary scheduling problem from structural underpayment. That expertise becomes persuasive when expressed in forms decision-makers can use, including service-level data, budget impact analysis and examples of care delayed or redirected.

Patients and families can describe the lived effects of delayed valve surgery, thoracic referral, prolonged rehabilitation or repeated travel to a major centre. Surgeons should never disclose identifying details without consent, and institutional stories should be checked against clinical records. The objective is not to overdramatise harm, but to show what a technical adjustment means when someone cannot access an operation, follow-up clinic or timely imaging.

Surgeons can also test proposals before they become policy. A replacement fee should be modelled against the hours required for the team, not just the surgeon’s time in theatre. Theatre utilisation, ICU occupancy, device costs, readmissions and cancellations should be presented together. This avoids cherry-picked figures and shows policymakers that an apparently fair average can disadvantage complex, unpredictable work.

Building an Australian advocacy network

Australian advocacy works best when national claims are grounded in local systems. Major cardiac and thoracic surgery programs operate in metropolitan centres such as Melbourne, Sydney, Brisbane and Adelaide, while regional and rural patients often depend on retrieval pathways to those hubs. That geography makes access more than an urban workforce issue. Evidence about travel, waiting times and transfers can show whether a payment change has a different impact outside capital cities.

National claims gain credibility when they connect clinical evidence with organisations able to act. Partners can include the Royal Australasian College of Surgeons, the Cardiac Society of Australia and New Zealand, the Heart Foundation, consumer advocates, private hospital groups, state health departments and rural clinicians. In Brisbane, supporting early-career researchers is also a practical way to connect service data with evidence that can withstand parliamentary scrutiny.

The network should include anaesthesia, perfusion, intensive-care, nursing and allied-health colleagues because their capacity shows how a surgical service works. Junior doctors and research fellows can maintain registries of procedure volumes, outcomes and access barriers. Australia’s division between Commonwealth funding and state-run hospitals makes coordination essential: a service may be clinically sustainable in one jurisdiction and financially exposed in another.

Turning evidence into effective advocacy

Advocacy succeeds when the same message appears in several settings with appropriate detail. A one-page clinical brief can accompany a submission to a Commonwealth consultation; a patient account can support a meeting with a state health minister; and a spokesperson can prepare local media for a national debate. Surgeons should define the ask early: preserve an essential service, fund a specific adjustment, require transparent modelling or commission an independent review.

Australian legislative pathways make documentation important. Parliamentary committees, Senate inquiries, health ministers and the Department of Health and Aged Care all seek evidence, but submissions must distinguish a fee proposal from a budget decision and identify the affected program. State systems add public hospital funding, while private insurers operate under separate contracts. Where a proposal may breach administrative law or lack evidence, legal teams can examine procedural options while clinicians supply the factual record.

Communication should respect how patients encounter the issue. Many first hear about access through a GP, then wait for a public outpatient clinic or elective operating-list assessment, while privately insured patients may see a gap before a claim is paid. Plain English matters, as does specifying the consequence of inaction. Local radio, hospital newsletters and professional publications can reach community audiences who rarely follow parliamentary pages, provided spokespeople use consistent messages.

Actions that strengthen the case

Campaigns are strongest when they convert concern into a coordinated programme rather than a burst of correspondence after an announcement. Cardiothoracic surgeons can establish an internal advocacy group, agree on core evidence and assign responsibilities before the next consultation or budget decision. This protects colleagues from making inconsistent claims and gives patients a reliable channel for sharing experiences.

Each service can begin with a small, durable evidence plan:

• Assemble a service-line evidence pack covering team time, theatre and ICU costs, cancellations, transfers, waiting times and outcomes in public and private activity.
• Compare current Medicare and insurer payments with the resources needed for safe, timely cardiac and thoracic care.
• Create a consent-based patient story process coordinated with privacy, legal and communications teams.
• Build coalitions with the Royal Australasian College of Surgeons, CSANZ, the Heart Foundation, rural clinicians, nurses, allied health and consumer advocates.
• Submit concise, technically reviewed recommendations to Commonwealth and state decision-makers during consultation periods.
• Equip spokespeople with accurate public messages and publish progress updates so supporters know what action has achieved.

Start with the next available data cycle rather than waiting for a national crisis. Practices that document costs and outcomes now can respond quickly, while patients asked to tell their stories will understand how their contributions are used. Collaboration should extend to junior doctors and researchers, whose work can reveal future workforce needs before they become service gaps.

Cardiothoracic surgeons can make the case for stable access now. Bring a multidisciplinary group together, select one patient-centred claim, and document the cost and consequence of any proposed reduction. Give patients a clear, consent-based route to participate and give decision-makers a specific request they can act on.

The next step belongs to every service, practice and patient who has seen access deteriorate. Share verified evidence, participate in consultations, support coordinated submissions and speak publicly with a consistent message. A united campaign can ensure fee reductions are judged by their effects on safe care rather than by a spreadsheet line alone.